A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam
1509-0002
Phase 1 other active
Quick answer
A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam for Healthy volunteer trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Healthy volunteer trial
- Phase
- Phase 1
- Modality
- other
- Status
- active